Studying blood clots on heart devices
Part of Heart & circulation clinical trials.
This study looks at patients who have a blood clot on the device placed in the heart to close off a small pouch (left atrial appendage). It aims to understand why these clots happen and how to manage them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a known or suspected blood clot on your left atrial appendage closure device.
- The clot was found by a special ultrasound or CT scan of the heart.
- You are able to give your permission to be in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two different devices (Amplatzer Amulet and LAmbre) used to close a small pouch in the heart called the left atrial appendage. People with atrial fibrillation who are at high risk for stroke and bleeding may be able to stop blood thinners after the procedure.
This trial compares a heart device that can help prevent blood clots in the heart (called LAAO) versus long-term blood thinners for people who have atrial fibrillation and recently had a stent placed. It aims to see which approach better prevents stroke and related blood-clot problems while keeping side effects manageable.
This study compares two devices (LAmbre and AMPLATZER Amulet) that are placed in the heart to prevent strokes in people with atrial fibrillation who cannot take blood thinners. If you join, you will be randomly assigned to get one of the two devices.
This trial is testing two ways to guide a procedure that closes a small pouch in the heart to lower the risk of stroke in people with atrial fibrillation. The goal is to see if one method is as good or better than the other.
This study tests whether closing a heart pocket called the left atrial appendage can lower future stroke or other clot-related events in people with atrial fibrillation. It’s mainly for people who have had a prior clot-related event or are at higher risk but may not be good candidates for long-term blood thinners.
This study looks at long-term outcomes after LAA closure (a procedure to reduce stroke risk) by reviewing CT scans of the device. It aims to learn if blood flow around the device affects healing and future health.
Hear when a new Percutaneous Left Atrial Appendage Occlusion (LAAO) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.